The impact of clopidogrel combined with aspirin or aspirin alone on prognosis and adverse events in patients undergoing coronary artery bypass grafting in the first month after surgery
BackgroundCoronary artery bypass grafting (CABG) was a critical intervention for patients with obstructive coronary artery disease, yet managing thrombotic complications post-surgery remains challenging. Aspirin was the standard antiplatelet therapy following CABG; however, the potential benefits of...
Saved in:
| Main Authors: | Haiming Li, Hui Hu, Jingxing Li, Chengxiong Gu, Bo Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1600353/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVALUATION OF ASPIRIN USAGE SAFETY IN CORONARY BYPASS SURGERY
by: A. M. Chernyavsky, et al.
Published: (2017-10-01) -
Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01) -
Endobronchial biopsies in patients receiving clopidogrel and aspirin treatment
by: Bilal Rabahoğlu, et al.
Published: (2025-07-01) -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01) -
Ticagrelor combined with aspirin may improve patency of vein graft one year after off-pump coronary artery bypass grafting: a single-center, randomized double-blinded clinical controlled trial
by: Wenjun Wang, et al.
Published: (2025-05-01)